GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-miR-218-5p
|
MIMAT0000275 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_93405352 | 33.52 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr4_+_158141843 | 31.16 |
ENST00000509417.1
ENST00000296526.7 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr16_+_58497567 | 30.19 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
chr12_-_16761007 | 30.08 |
ENST00000354662.1
ENST00000441439.2 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr5_-_176057365 | 30.03 |
ENST00000310112.3
|
SNCB
|
synuclein, beta |
chr12_+_79258547 | 29.89 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr11_-_134281812 | 29.36 |
ENST00000392580.1
ENST00000312527.4 |
B3GAT1
|
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
chr11_+_62475130 | 28.24 |
ENST00000294117.5
|
GNG3
|
guanine nucleotide binding protein (G protein), gamma 3 |
chr3_+_11034403 | 27.43 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
chr16_-_19896220 | 27.10 |
ENST00000562469.1
ENST00000300571.2 |
GPRC5B
|
G protein-coupled receptor, family C, group 5, member B |
chr19_+_19322758 | 26.79 |
ENST00000252575.6
|
NCAN
|
neurocan |
chr15_+_91643442 | 26.76 |
ENST00000394232.1
|
SV2B
|
synaptic vesicle glycoprotein 2B |
chr13_+_27131887 | 26.11 |
ENST00000335327.5
|
WASF3
|
WAS protein family, member 3 |
chr2_+_231729615 | 24.78 |
ENST00000326427.6
ENST00000335005.6 ENST00000326407.6 |
ITM2C
|
integral membrane protein 2C |
chr9_+_130374537 | 24.40 |
ENST00000373302.3
ENST00000373299.1 |
STXBP1
|
syntaxin binding protein 1 |
chr1_-_41131326 | 23.92 |
ENST00000372684.3
|
RIMS3
|
regulating synaptic membrane exocytosis 3 |
chr5_-_11904152 | 23.15 |
ENST00000304623.8
ENST00000458100.2 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
chrX_+_110339439 | 22.32 |
ENST00000372010.1
ENST00000519681.1 ENST00000372007.5 |
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3 |
chr3_+_238273 | 21.51 |
ENST00000256509.2
|
CHL1
|
cell adhesion molecule L1-like |
chr2_-_26205340 | 21.44 |
ENST00000264712.3
|
KIF3C
|
kinesin family member 3C |
chr2_-_2334888 | 21.41 |
ENST00000428368.2
ENST00000399161.2 |
MYT1L
|
myelin transcription factor 1-like |
chr20_+_34700333 | 21.20 |
ENST00000441639.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr3_+_49591881 | 20.46 |
ENST00000296452.4
|
BSN
|
bassoon presynaptic cytomatrix protein |
chr9_-_91793675 | 20.43 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
chr22_-_39548627 | 20.43 |
ENST00000216133.5
|
CBX7
|
chromobox homolog 7 |
chr7_+_153584166 | 19.43 |
ENST00000404039.1
|
DPP6
|
dipeptidyl-peptidase 6 |
chr2_+_79740118 | 19.37 |
ENST00000496558.1
ENST00000451966.1 |
CTNNA2
|
catenin (cadherin-associated protein), alpha 2 |
chr1_-_21978312 | 18.32 |
ENST00000359708.4
ENST00000290101.4 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr16_+_56225248 | 17.74 |
ENST00000262493.6
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
chr1_-_149889382 | 16.29 |
ENST00000369145.1
ENST00000369146.3 |
SV2A
|
synaptic vesicle glycoprotein 2A |
chr7_+_86273218 | 16.28 |
ENST00000361669.2
|
GRM3
|
glutamate receptor, metabotropic 3 |
chr8_-_18871159 | 15.35 |
ENST00000327040.8
ENST00000440756.2 |
PSD3
|
pleckstrin and Sec7 domain containing 3 |
chr16_+_22825475 | 15.26 |
ENST00000261374.3
|
HS3ST2
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
chr11_-_12030629 | 14.97 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr6_+_69345166 | 14.81 |
ENST00000370598.1
|
BAI3
|
brain-specific angiogenesis inhibitor 3 |
chr2_-_50574856 | 14.54 |
ENST00000342183.5
|
NRXN1
|
neurexin 1 |
chr3_-_56502375 | 14.40 |
ENST00000288221.6
|
ERC2
|
ELKS/RAB6-interacting/CAST family member 2 |
chr6_+_121756809 | 14.35 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
chr14_+_90863327 | 14.31 |
ENST00000356978.4
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta) |
chrX_+_153665248 | 13.50 |
ENST00000447750.2
|
GDI1
|
GDP dissociation inhibitor 1 |
chr20_-_4804244 | 13.31 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr7_+_97361218 | 13.25 |
ENST00000319273.5
|
TAC1
|
tachykinin, precursor 1 |
chr15_+_75287861 | 13.18 |
ENST00000425597.3
ENST00000562327.1 ENST00000568018.1 ENST00000562212.1 ENST00000567920.1 ENST00000566872.1 ENST00000361900.6 ENST00000545456.1 |
SCAMP5
|
secretory carrier membrane protein 5 |
chr16_+_1756162 | 13.03 |
ENST00000250894.4
ENST00000356010.5 |
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3 |
chr3_-_66551351 | 12.79 |
ENST00000273261.3
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
chr5_+_76506706 | 12.43 |
ENST00000340978.3
ENST00000346042.3 ENST00000264917.5 ENST00000342343.4 ENST00000333194.4 |
PDE8B
|
phosphodiesterase 8B |
chr3_+_33318914 | 12.05 |
ENST00000484457.1
ENST00000538892.1 ENST00000538181.1 ENST00000446237.3 ENST00000507198.1 |
FBXL2
|
F-box and leucine-rich repeat protein 2 |
chr1_-_57045228 | 12.01 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr1_-_109584608 | 11.92 |
ENST00000400794.3
ENST00000528747.1 ENST00000369962.3 ENST00000361054.3 |
WDR47
|
WD repeat domain 47 |
chr7_-_79082867 | 11.89 |
ENST00000419488.1
ENST00000354212.4 |
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr2_+_173600671 | 11.72 |
ENST00000409036.1
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr2_+_159313452 | 11.51 |
ENST00000389757.3
ENST00000389759.3 |
PKP4
|
plakophilin 4 |
chr19_-_17799008 | 11.25 |
ENST00000519716.2
|
UNC13A
|
unc-13 homolog A (C. elegans) |
chr10_-_97321112 | 11.22 |
ENST00000607232.1
ENST00000371227.4 ENST00000371249.2 ENST00000371247.2 ENST00000371246.2 ENST00000393949.1 ENST00000353505.5 ENST00000347291.4 |
SORBS1
|
sorbin and SH3 domain containing 1 |
chr4_-_99579733 | 11.21 |
ENST00000305798.3
|
TSPAN5
|
tetraspanin 5 |
chr20_+_2854066 | 11.15 |
ENST00000455631.1
ENST00000216877.6 ENST00000399903.2 ENST00000358719.4 ENST00000431048.1 ENST00000425918.2 ENST00000430705.1 ENST00000318266.5 |
PTPRA
|
protein tyrosine phosphatase, receptor type, A |
chr7_-_103629963 | 10.80 |
ENST00000428762.1
ENST00000343529.5 ENST00000424685.2 |
RELN
|
reelin |
chr17_-_40021656 | 10.70 |
ENST00000319121.3
|
KLHL11
|
kelch-like family member 11 |
chr20_-_48099182 | 10.42 |
ENST00000371741.4
|
KCNB1
|
potassium voltage-gated channel, Shab-related subfamily, member 1 |
chr15_-_52861394 | 10.38 |
ENST00000563277.1
ENST00000566423.1 |
ARPP19
|
cAMP-regulated phosphoprotein, 19kDa |
chr14_+_85996471 | 10.33 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr6_+_148663729 | 10.25 |
ENST00000367467.3
|
SASH1
|
SAM and SH3 domain containing 1 |
chr18_-_53255766 | 10.15 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
chr18_+_21693306 | 10.13 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
chr16_-_68482440 | 9.75 |
ENST00000219334.5
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
chr17_+_53342311 | 9.53 |
ENST00000226067.5
|
HLF
|
hepatic leukemia factor |
chr7_-_44924939 | 9.52 |
ENST00000395699.2
|
PURB
|
purine-rich element binding protein B |
chr14_-_77843390 | 9.46 |
ENST00000216468.7
|
TMED8
|
transmembrane emp24 protein transport domain containing 8 |
chr4_+_62066941 | 9.45 |
ENST00000512091.2
|
LPHN3
|
latrophilin 3 |
chr12_+_41086297 | 9.44 |
ENST00000551295.2
|
CNTN1
|
contactin 1 |
chr11_+_113930291 | 9.38 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
chr7_+_106685079 | 9.18 |
ENST00000265717.4
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta |
chr13_-_53422640 | 9.16 |
ENST00000338862.4
ENST00000377942.3 |
PCDH8
|
protocadherin 8 |
chr2_-_86850949 | 9.10 |
ENST00000237455.4
|
RNF103
|
ring finger protein 103 |
chr1_-_6321035 | 8.77 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
chr9_+_34958254 | 8.75 |
ENST00000242315.3
|
KIAA1045
|
KIAA1045 |
chr5_-_115910630 | 8.71 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr14_+_69658194 | 8.57 |
ENST00000409018.3
ENST00000409014.1 ENST00000409675.1 |
EXD2
|
exonuclease 3'-5' domain containing 2 |
chr14_+_79745746 | 8.57 |
ENST00000281127.7
|
NRXN3
|
neurexin 3 |
chr2_-_47798044 | 8.56 |
ENST00000327876.4
|
KCNK12
|
potassium channel, subfamily K, member 12 |
chr8_-_53322303 | 8.48 |
ENST00000276480.7
|
ST18
|
suppression of tumorigenicity 18 (breast carcinoma) (zinc finger protein) |
chr20_-_41818373 | 8.28 |
ENST00000373187.1
ENST00000356100.2 ENST00000373184.1 ENST00000373190.1 |
PTPRT
|
protein tyrosine phosphatase, receptor type, T |
chr11_-_118047376 | 8.23 |
ENST00000278947.5
|
SCN2B
|
sodium channel, voltage-gated, type II, beta subunit |
chr10_+_96162242 | 8.19 |
ENST00000225235.4
|
TBC1D12
|
TBC1 domain family, member 12 |
chr6_+_96463840 | 8.04 |
ENST00000302103.5
|
FUT9
|
fucosyltransferase 9 (alpha (1,3) fucosyltransferase) |
chr14_-_51562745 | 7.98 |
ENST00000298355.3
|
TRIM9
|
tripartite motif containing 9 |
chr4_+_85504075 | 7.94 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
chr18_-_11148587 | 7.91 |
ENST00000302079.6
ENST00000580640.1 ENST00000503781.3 |
PIEZO2
|
piezo-type mechanosensitive ion channel component 2 |
chr15_+_59063478 | 7.74 |
ENST00000559228.1
ENST00000450403.2 |
FAM63B
|
family with sequence similarity 63, member B |
chr5_+_67511524 | 7.71 |
ENST00000521381.1
ENST00000521657.1 |
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
chr11_-_45307817 | 7.67 |
ENST00000020926.3
|
SYT13
|
synaptotagmin XIII |
chr1_-_200992827 | 7.66 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
chr11_+_111473108 | 7.64 |
ENST00000304987.3
|
SIK2
|
salt-inducible kinase 2 |
chrX_-_153237258 | 7.60 |
ENST00000310441.7
|
HCFC1
|
host cell factor C1 (VP16-accessory protein) |
chr19_-_14316980 | 7.59 |
ENST00000361434.3
ENST00000340736.6 |
LPHN1
|
latrophilin 1 |
chr20_-_47894569 | 7.54 |
ENST00000371744.1
ENST00000371752.1 ENST00000396105.1 |
ZNFX1
|
zinc finger, NFX1-type containing 1 |
chr11_+_118401706 | 7.42 |
ENST00000411589.2
ENST00000442938.2 ENST00000359862.4 |
TMEM25
|
transmembrane protein 25 |
chr3_-_192445289 | 7.40 |
ENST00000430714.1
ENST00000418610.1 ENST00000448795.1 ENST00000445105.2 |
FGF12
|
fibroblast growth factor 12 |
chr7_-_121036337 | 7.36 |
ENST00000426156.1
ENST00000359943.3 ENST00000412653.1 |
FAM3C
|
family with sequence similarity 3, member C |
chr2_-_166930131 | 7.33 |
ENST00000303395.4
ENST00000409050.1 ENST00000423058.2 ENST00000375405.3 |
SCN1A
|
sodium channel, voltage-gated, type I, alpha subunit |
chr11_-_118661828 | 7.13 |
ENST00000264018.4
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
chr14_+_74111578 | 7.05 |
ENST00000554113.1
ENST00000555631.2 ENST00000553645.2 ENST00000311089.3 ENST00000555919.3 ENST00000554339.1 ENST00000554871.1 |
DNAL1
|
dynein, axonemal, light chain 1 |
chr5_+_140306478 | 7.02 |
ENST00000253807.2
|
PCDHAC1
|
protocadherin alpha subfamily C, 1 |
chr13_-_67804445 | 6.92 |
ENST00000456367.1
ENST00000377861.3 ENST00000544246.1 |
PCDH9
|
protocadherin 9 |
chrX_+_56259316 | 6.90 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr5_+_140220769 | 6.76 |
ENST00000531613.1
ENST00000378123.3 |
PCDHA8
|
protocadherin alpha 8 |
chr22_+_25202232 | 6.73 |
ENST00000400358.4
ENST00000400359.4 |
SGSM1
|
small G protein signaling modulator 1 |
chr12_-_54673871 | 6.69 |
ENST00000209875.4
|
CBX5
|
chromobox homolog 5 |
chr17_-_33416231 | 6.47 |
ENST00000584655.1
ENST00000447669.2 ENST00000315249.7 |
RFFL
|
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
chr10_+_99344104 | 6.46 |
ENST00000555577.1
ENST00000370649.3 |
PI4K2A
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha Phosphatidylinositol 4-kinase type 2-alpha; Uncharacterized protein |
chr10_-_104474128 | 6.45 |
ENST00000260746.5
|
ARL3
|
ADP-ribosylation factor-like 3 |
chr18_+_42260861 | 6.40 |
ENST00000282030.5
|
SETBP1
|
SET binding protein 1 |
chr14_+_32546485 | 6.37 |
ENST00000345122.3
ENST00000432921.1 ENST00000433497.1 |
ARHGAP5
|
Rho GTPase activating protein 5 |
chr5_+_140254884 | 6.28 |
ENST00000398631.2
|
PCDHA12
|
protocadherin alpha 12 |
chr10_+_76871454 | 6.25 |
ENST00000372687.4
|
SAMD8
|
sterile alpha motif domain containing 8 |
chr10_+_104678032 | 6.24 |
ENST00000369878.4
ENST00000369875.3 |
CNNM2
|
cyclin M2 |
chr2_-_152955537 | 6.21 |
ENST00000201943.5
ENST00000539935.1 |
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit |
chr20_+_58508817 | 6.20 |
ENST00000358293.3
|
FAM217B
|
family with sequence similarity 217, member B |
chr19_+_1752372 | 6.15 |
ENST00000382349.4
|
ONECUT3
|
one cut homeobox 3 |
chr5_+_140227048 | 6.15 |
ENST00000532602.1
|
PCDHA9
|
protocadherin alpha 9 |
chr5_+_140213815 | 6.13 |
ENST00000525929.1
ENST00000378125.3 |
PCDHA7
|
protocadherin alpha 7 |
chr1_-_118472216 | 6.12 |
ENST00000369443.5
|
GDAP2
|
ganglioside induced differentiation associated protein 2 |
chr11_-_70507901 | 6.08 |
ENST00000449833.2
ENST00000357171.3 ENST00000449116.2 |
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
chr5_+_140248518 | 6.04 |
ENST00000398640.2
|
PCDHA11
|
protocadherin alpha 11 |
chr17_+_14204389 | 5.99 |
ENST00000360954.2
|
HS3ST3B1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
chr15_-_77363513 | 5.95 |
ENST00000267970.4
|
TSPAN3
|
tetraspanin 3 |
chr6_+_43543942 | 5.91 |
ENST00000372226.1
ENST00000443535.1 |
POLH
|
polymerase (DNA directed), eta |
chr8_+_86376081 | 5.85 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
chr4_-_10686475 | 5.66 |
ENST00000226951.6
|
CLNK
|
cytokine-dependent hematopoietic cell linker |
chr3_+_32147997 | 5.62 |
ENST00000282541.5
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like |
chr18_+_13218769 | 5.58 |
ENST00000399848.3
ENST00000361205.4 |
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4 |
chr5_+_139493665 | 5.56 |
ENST00000331327.3
|
PURA
|
purine-rich element binding protein A |
chr12_+_72666407 | 5.51 |
ENST00000261180.4
|
TRHDE
|
thyrotropin-releasing hormone degrading enzyme |
chr3_+_57541975 | 5.48 |
ENST00000487257.1
ENST00000311180.8 |
PDE12
|
phosphodiesterase 12 |
chr1_+_220701456 | 5.44 |
ENST00000366918.4
ENST00000402574.1 |
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
chr5_+_140345820 | 5.44 |
ENST00000289269.5
|
PCDHAC2
|
protocadherin alpha subfamily C, 2 |
chr9_-_123476719 | 5.35 |
ENST00000373930.3
|
MEGF9
|
multiple EGF-like-domains 9 |
chr12_-_89918522 | 5.33 |
ENST00000529983.2
|
GALNT4
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) |
chr2_+_172544182 | 5.32 |
ENST00000409197.1
ENST00000456808.1 ENST00000409317.1 ENST00000409773.1 ENST00000411953.1 ENST00000409453.1 |
DYNC1I2
|
dynein, cytoplasmic 1, intermediate chain 2 |
chr17_+_5031687 | 5.32 |
ENST00000250066.6
ENST00000304328.5 |
USP6
|
ubiquitin specific peptidase 6 (Tre-2 oncogene) |
chr9_+_131843377 | 5.29 |
ENST00000372546.4
ENST00000406974.3 ENST00000540102.1 |
DOLPP1
|
dolichyldiphosphatase 1 |
chr13_+_97874574 | 5.25 |
ENST00000343600.4
ENST00000345429.6 ENST00000376673.3 |
MBNL2
|
muscleblind-like splicing regulator 2 |
chr1_+_184356188 | 5.25 |
ENST00000235307.6
|
C1orf21
|
chromosome 1 open reading frame 21 |
chr12_+_31812602 | 5.16 |
ENST00000538463.1
ENST00000357721.3 ENST00000539633.1 |
METTL20
|
methyltransferase like 20 |
chr1_-_208417620 | 5.16 |
ENST00000367033.3
|
PLXNA2
|
plexin A2 |
chr4_+_115519577 | 5.15 |
ENST00000310836.6
|
UGT8
|
UDP glycosyltransferase 8 |
chr11_-_78052923 | 5.12 |
ENST00000340149.2
|
GAB2
|
GRB2-associated binding protein 2 |
chr6_-_128841503 | 5.10 |
ENST00000368215.3
ENST00000532331.1 ENST00000368213.5 ENST00000368207.3 ENST00000525459.1 ENST00000368210.3 ENST00000368226.4 ENST00000368227.3 |
PTPRK
|
protein tyrosine phosphatase, receptor type, K |
chr2_-_213403565 | 5.08 |
ENST00000342788.4
ENST00000436443.1 |
ERBB4
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
chr17_+_48638371 | 5.02 |
ENST00000360761.4
ENST00000352832.5 ENST00000354983.4 |
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr11_-_73472096 | 5.02 |
ENST00000541588.1
ENST00000336083.3 ENST00000540771.1 ENST00000310653.6 |
RAB6A
|
RAB6A, member RAS oncogene family |
chr15_+_78441663 | 4.89 |
ENST00000299518.2
ENST00000558554.1 ENST00000557826.1 ENST00000561279.1 ENST00000559186.1 ENST00000560770.1 ENST00000559881.1 ENST00000559205.1 ENST00000441490.2 |
IDH3A
|
isocitrate dehydrogenase 3 (NAD+) alpha |
chr11_+_73882144 | 4.87 |
ENST00000328257.8
|
PPME1
|
protein phosphatase methylesterase 1 |
chrX_+_133507327 | 4.83 |
ENST00000332070.3
ENST00000394292.1 ENST00000370799.1 ENST00000416404.2 |
PHF6
|
PHD finger protein 6 |
chr19_-_38714847 | 4.76 |
ENST00000420980.2
ENST00000355526.4 |
DPF1
|
D4, zinc and double PHD fingers family 1 |
chr12_+_120875910 | 4.70 |
ENST00000551806.1
|
AL021546.6
|
Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial |
chr13_+_58206655 | 4.65 |
ENST00000377918.3
|
PCDH17
|
protocadherin 17 |
chr4_+_55524085 | 4.40 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
chr8_-_93115445 | 4.39 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr2_-_99224915 | 4.38 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
chr2_+_5832799 | 4.34 |
ENST00000322002.3
|
SOX11
|
SRY (sex determining region Y)-box 11 |
chr9_-_73029540 | 4.31 |
ENST00000377126.2
|
KLF9
|
Kruppel-like factor 9 |
chr8_-_82024290 | 4.25 |
ENST00000220597.4
|
PAG1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
chr4_+_99182593 | 4.25 |
ENST00000508213.1
ENST00000408927.3 ENST00000514122.1 ENST00000453712.2 ENST00000511212.1 ENST00000408900.3 ENST00000339360.5 |
RAP1GDS1
|
RAP1, GTP-GDP dissociation stimulator 1 |
chr10_+_126490354 | 4.23 |
ENST00000298492.5
|
FAM175B
|
family with sequence similarity 175, member B |
chr17_-_62207485 | 4.20 |
ENST00000433197.3
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1 |
chr9_+_129089088 | 4.17 |
ENST00000361171.3
ENST00000545391.1 |
MVB12B
|
multivesicular body subunit 12B |
chr1_-_52831796 | 4.13 |
ENST00000284376.3
ENST00000438831.1 ENST00000371586.2 |
CC2D1B
|
coiled-coil and C2 domain containing 1B |
chr15_-_86338134 | 4.08 |
ENST00000337975.5
|
KLHL25
|
kelch-like family member 25 |
chr5_-_132299313 | 4.07 |
ENST00000265343.5
|
AFF4
|
AF4/FMR2 family, member 4 |
chr20_+_3451650 | 4.06 |
ENST00000262919.5
|
ATRN
|
attractin |
chrX_+_24167746 | 4.03 |
ENST00000428571.1
ENST00000539115.1 |
ZFX
|
zinc finger protein, X-linked |
chr7_+_99613195 | 4.02 |
ENST00000324306.6
|
ZKSCAN1
|
zinc finger with KRAB and SCAN domains 1 |
chr16_+_19535133 | 4.01 |
ENST00000396212.2
ENST00000381396.5 |
CCP110
|
centriolar coiled coil protein 110kDa |
chr1_+_41249539 | 3.99 |
ENST00000347132.5
ENST00000509682.2 |
KCNQ4
|
potassium voltage-gated channel, KQT-like subfamily, member 4 |
chr12_+_5019061 | 3.92 |
ENST00000382545.3
|
KCNA1
|
potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) |
chr8_+_12803176 | 3.91 |
ENST00000524591.2
|
KIAA1456
|
KIAA1456 |
chr9_+_112403088 | 3.91 |
ENST00000448454.2
|
PALM2
|
paralemmin 2 |
chr17_+_46125707 | 3.89 |
ENST00000584137.1
ENST00000362042.3 ENST00000585291.1 ENST00000357480.5 |
NFE2L1
|
nuclear factor, erythroid 2-like 1 |
chr12_-_89919965 | 3.88 |
ENST00000548729.1
|
POC1B-GALNT4
|
POC1B-GALNT4 readthrough |
chr9_-_3525968 | 3.85 |
ENST00000382004.3
ENST00000302303.1 ENST00000449190.1 |
RFX3
|
regulatory factor X, 3 (influences HLA class II expression) |
chr5_-_9546180 | 3.78 |
ENST00000382496.5
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
chr1_+_174769006 | 3.73 |
ENST00000489615.1
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr15_-_25684110 | 3.69 |
ENST00000232165.3
|
UBE3A
|
ubiquitin protein ligase E3A |
chr9_+_131873591 | 3.66 |
ENST00000393370.2
ENST00000337738.1 ENST00000348141.5 |
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4 |
chr5_-_112630598 | 3.66 |
ENST00000302475.4
|
MCC
|
mutated in colorectal cancers |
chr5_+_140165876 | 3.65 |
ENST00000504120.2
ENST00000394633.3 ENST00000378133.3 |
PCDHA1
|
protocadherin alpha 1 |
chr7_+_49813255 | 3.64 |
ENST00000340652.4
|
VWC2
|
von Willebrand factor C domain containing 2 |
chr19_+_34112850 | 3.64 |
ENST00000591231.1
ENST00000434302.1 ENST00000438847.3 |
CHST8
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 |
chr12_-_100536608 | 3.51 |
ENST00000356828.3
ENST00000279907.7 |
UHRF1BP1L
|
UHRF1 binding protein 1-like |
chr12_-_71148413 | 3.49 |
ENST00000440835.2
ENST00000549308.1 ENST00000550661.1 |
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
chr7_+_138916231 | 3.45 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
chr11_+_119076745 | 3.45 |
ENST00000264033.4
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase |
chr12_+_120884222 | 3.37 |
ENST00000551765.1
ENST00000229384.5 |
GATC
|
glutamyl-tRNA(Gln) amidotransferase, subunit C |
chrX_-_153363188 | 3.33 |
ENST00000303391.6
|
MECP2
|
methyl CpG binding protein 2 (Rett syndrome) |
chr18_-_44336998 | 3.31 |
ENST00000315087.7
|
ST8SIA5
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
chr18_+_33877654 | 3.29 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr7_-_71801980 | 3.27 |
ENST00000329008.5
|
CALN1
|
calneuron 1 |
chr3_+_39093481 | 3.24 |
ENST00000302313.5
ENST00000544962.1 ENST00000396258.3 ENST00000418020.1 |
WDR48
|
WD repeat domain 48 |
chr13_-_40177261 | 3.24 |
ENST00000379589.3
|
LHFP
|
lipoma HMGIC fusion partner |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 29.9 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
8.9 | 35.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
6.9 | 27.4 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
6.1 | 18.3 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
5.9 | 11.9 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
5.0 | 30.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
4.4 | 13.2 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
4.3 | 12.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.7 | 15.0 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
3.6 | 14.4 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
3.3 | 16.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
3.1 | 3.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
3.1 | 24.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
2.9 | 8.7 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
2.8 | 5.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
2.7 | 10.8 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.6 | 10.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
2.6 | 10.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.6 | 10.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.4 | 7.1 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
2.3 | 4.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
2.3 | 30.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.9 | 5.8 | GO:0042938 | dipeptide transport(GO:0042938) |
1.9 | 7.6 | GO:0019046 | release from viral latency(GO:0019046) |
1.9 | 13.3 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.9 | 3.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
1.9 | 9.4 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) positive regulation of NK T cell differentiation(GO:0051138) germline stem cell asymmetric division(GO:0098728) |
1.8 | 9.2 | GO:0097338 | response to clozapine(GO:0097338) |
1.8 | 14.5 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.7 | 22.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.7 | 5.1 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
1.7 | 13.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.6 | 6.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.6 | 27.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.5 | 4.4 | GO:0048170 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.4 | 4.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
1.4 | 56.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.3 | 3.8 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
1.2 | 2.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.2 | 2.4 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
1.2 | 17.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.1 | 16.0 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
1.1 | 5.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.1 | 7.9 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
1.1 | 3.3 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
1.1 | 13.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.0 | 4.0 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.0 | 3.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.0 | 2.9 | GO:1900158 | negative regulation of osteoclast proliferation(GO:0090291) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.9 | 3.7 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.9 | 14.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.9 | 21.9 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.9 | 3.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.9 | 26.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.9 | 11.3 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.9 | 8.6 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.8 | 5.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.8 | 20.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.8 | 21.6 | GO:0048665 | neuron fate specification(GO:0048665) |
0.8 | 9.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.8 | 15.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.8 | 5.3 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.8 | 28.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.7 | 3.0 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.7 | 7.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.7 | 5.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.7 | 7.9 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.7 | 4.3 | GO:0051414 | response to cortisol(GO:0051414) |
0.7 | 2.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.7 | 3.4 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.7 | 7.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.7 | 7.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.7 | 8.0 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.7 | 2.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.7 | 5.3 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.7 | 8.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.6 | 1.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 30.0 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.6 | 1.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 6.8 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.6 | 1.9 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.6 | 10.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.6 | 2.4 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.6 | 27.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.6 | 7.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 27.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 27.9 | GO:0042073 | intraciliary transport(GO:0042073) |
0.6 | 5.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 1.6 | GO:0007497 | posterior midgut development(GO:0007497) |
0.5 | 3.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.5 | 6.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.5 | 2.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.5 | 5.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 3.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.5 | 3.0 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.5 | 23.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 4.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.5 | 75.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 5.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 20.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.4 | 11.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.4 | 3.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.4 | 13.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.4 | 2.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 2.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 11.8 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 2.7 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.4 | 2.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 10.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.3 | 1.4 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 4.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 1.0 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 4.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.3 | 2.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.3 | 1.0 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 6.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 1.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 22.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 6.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.3 | 4.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 9.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.3 | 2.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.3 | 8.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 7.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 3.6 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.3 | 1.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 2.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.7 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.2 | 1.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 3.0 | GO:0045008 | depyrimidination(GO:0045008) |
0.2 | 0.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) motor behavior(GO:0061744) |
0.2 | 2.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 16.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.2 | 1.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 6.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 1.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 3.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 15.3 | GO:0006024 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
0.2 | 6.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 3.3 | GO:0060384 | innervation(GO:0060384) |
0.2 | 13.5 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 1.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.2 | 3.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 2.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 2.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 4.1 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.1 | 8.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 3.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 2.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 14.6 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 5.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.7 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 1.9 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.7 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.3 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 1.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 1.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 8.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.5 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) C-5 methylation of cytosine(GO:0090116) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 1.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 2.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 2.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 14.0 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.1 | 6.3 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.1 | 1.7 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.6 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 7.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 7.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.6 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 4.4 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 1.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 1.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 1.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 3.0 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 1.3 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 1.9 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.8 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 1.8 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 3.2 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 2.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 1.5 | GO:0007004 | telomere maintenance via telomerase(GO:0007004) |
0.0 | 1.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.4 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.6 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.0 | 1.6 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 31.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
6.0 | 29.9 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
4.1 | 20.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
3.1 | 9.4 | GO:0044305 | calyx of Held(GO:0044305) |
2.2 | 11.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.2 | 8.7 | GO:0035838 | growing cell tip(GO:0035838) |
1.9 | 7.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
1.8 | 75.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.5 | 11.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.4 | 9.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.0 | 4.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.0 | 7.1 | GO:0001520 | outer dense fiber(GO:0001520) |
1.0 | 15.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.0 | 3.0 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.9 | 5.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 15.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 7.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.8 | 5.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.8 | 11.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.8 | 14.4 | GO:0005922 | connexon complex(GO:0005922) |
0.7 | 2.9 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.6 | 44.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 6.1 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 4.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.6 | 7.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 24.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 13.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.5 | 26.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.5 | 37.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.5 | 5.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 9.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 7.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.4 | 22.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 1.9 | GO:0031905 | early endosome lumen(GO:0031905) |
0.4 | 11.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 6.7 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 0.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 36.8 | GO:0016234 | inclusion body(GO:0016234) |
0.3 | 2.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 3.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 25.5 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.2 | 12.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 10.5 | GO:0030496 | midbody(GO:0030496) |
0.2 | 6.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 66.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 27.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 24.0 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 4.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 2.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 6.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 3.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 4.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 5.3 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 4.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 53.3 | GO:0030424 | axon(GO:0030424) |
0.1 | 13.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 15.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 1.9 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 1.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.1 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 33.3 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 5.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 2.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 3.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 2.3 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 5.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 11.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 66.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 9.0 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 22.5 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 2.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 2.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 7.5 | GO:0098793 | presynapse(GO:0098793) |
0.1 | 5.6 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 2.7 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.1 | 6.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 4.0 | GO:0005814 | centriole(GO:0005814) |
0.1 | 3.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.5 | GO:0001741 | XY body(GO:0001741) |
0.0 | 1.0 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 2.9 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 55.3 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 2.1 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 7.8 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 2.4 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 7.5 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.0 | 0.9 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 11.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.8 | 29.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
6.0 | 29.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
4.6 | 27.4 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
4.0 | 11.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
3.6 | 10.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
3.5 | 21.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
3.3 | 16.3 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
2.6 | 7.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.6 | 31.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.4 | 14.4 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
2.3 | 23.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
2.2 | 8.7 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
2.2 | 6.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.1 | 30.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
2.1 | 6.2 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
1.9 | 5.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.8 | 9.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.7 | 8.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.6 | 8.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.6 | 17.7 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.4 | 23.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.4 | 8.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.4 | 35.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.4 | 16.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.3 | 24.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.3 | 7.9 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.2 | 4.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.0 | 8.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.0 | 9.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.9 | 3.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 19.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.9 | 6.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 10.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.8 | 23.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.8 | 3.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.8 | 10.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.8 | 22.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.7 | 3.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.7 | 7.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.7 | 5.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.7 | 18.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 8.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 16.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.6 | 12.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.6 | 3.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.6 | 15.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 2.9 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.6 | 2.9 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 9.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 9.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.6 | 2.8 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.6 | 9.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 13.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.5 | 5.3 | GO:0016462 | pyrophosphatase activity(GO:0016462) |
0.5 | 3.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 1.5 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.5 | 1.9 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.5 | 2.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.5 | 9.2 | GO:0008603 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 6.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 4.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 26.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 26.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.3 | 12.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 15.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.3 | 1.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 7.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 6.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 3.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.3 | 5.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 13.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 5.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 3.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 4.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 3.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 40.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 5.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 9.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 8.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 7.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 25.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 1.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 2.1 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.5 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.2 | 5.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.2 | 13.3 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.2 | 7.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 2.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 12.3 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 1.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 3.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 4.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 1.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 2.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 4.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 3.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.5 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 6.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 2.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 2.2 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 5.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 6.7 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 3.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 1.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 8.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 57.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 24.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 3.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 5.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.9 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 15.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 1.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 1.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 1.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 5.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.6 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 1.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 2.1 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 3.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 3.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 1.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 5.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 4.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 1.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.7 | GO:0046983 | protein dimerization activity(GO:0046983) |
0.0 | 0.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 55.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.8 | 42.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.7 | 25.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.7 | 36.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.6 | 21.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 15.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 17.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 3.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 10.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 9.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 4.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 3.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 4.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 5.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 9.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 7.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 4.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 2.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 6.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 2.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 13.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 6.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 23.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 3.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 3.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 1.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 54.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.5 | 56.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.4 | 27.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 44.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.1 | 31.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.1 | 19.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.1 | 21.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.9 | 21.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.9 | 14.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.8 | 15.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 18.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.7 | 31.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.6 | 8.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 12.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 13.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 11.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 5.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.4 | 5.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 11.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 12.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 5.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 6.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 3.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 5.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 13.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 10.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 5.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 3.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 9.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 1.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 1.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 5.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 4.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 6.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.9 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 3.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 2.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 2.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 2.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 3.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.9 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 5.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 13.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 1.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 1.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 2.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 1.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |